Skip to main content
. 2021 Jan 25;62(2):164–171. doi: 10.3349/ymj.2021.62.2.164

Table 1. Clinical and Demographic Characteristics of the Patients.

Non-induction group (n=195) Induction group (n=41) p value
Male sex 116 (59.5) 32 (78.0) 0.040
Age (yr) 52.7±12.5 57.5±9.3 0.006
BMI 20.8±3.7 22.7±4.8 0.017
Diagnosis 0.065
 COPD and emphysema 6 (3.1) 4 (9.8)
 Interstitial lung disease 142 (72.8) 32 (78.0)
 Bronchiectasis 13 (6.7) 3 (7.3)
 Others 34 (17.4) 2 (4.9)
Comorbidities
 Diabetes mellitus 26 (13.3) 11 (26.8) 0.054
 Hypertension 15 (7.7) 7 (17.1) 0.075
 Chronic renal disease 19 (9.7) 4 (9.8) 1.000
 Malignancies 29 (14.9) 1 (2.4) 0.056
Baseline creatinine levels (mg/dL) 0.65±0.22 0.53±0.20 0.003
Time on waiting list (days) 82.0 [24.0;171.0] 121.0 [29.0;244.0] 0.102
Pretransplantational admission 93 (47.7) 39 (95.1) <0.001
Pretransplantational admission duration (days) 0.0 [0.0;2.0] 32.0 [23.0;72.0] <0.001
Pretransplantational ICU care 66 (33.8) 37 (90.2) <0.001
Pretransplantational ICU care duration (days) 0.0 [0.0;8.0] 16 [11.0;28.0] <0.001
Pretransplantational ventilator care 60 (30.8) 37 (90.2) <0.001
Pretransplantational ventilator care duration (days) 0.0 [0.0;5.5] 14.0 [2.0;21.0] <0.001
Pretransplantational ECMO support 39 (20.0) 36 (87.8) <0.001
Pretransplantational ECMO support duration (days) 0.0 [0.0;0.0] 12.0 [6.0;22.0] <0.001

BMI, body mass index; COPD, chronic obstructive pulmonary disease; ECMO, extracorporeal membrane oxygenation; ICU, intensive care unit.

Data are presented as mean±standard deviation or n (%).